India
· Delayed Price · Currency is INR Aarti Pharmalabs Company Description
Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications.
It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acidic and allied products comprising sulphuric acid, sulphur trioxide, oleum, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate.
The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.
| Country | India |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,095 |
Contact Details
Address: 204, Udyog Kshetra Mumbai, 400 080 India | |
| Phone | 91 22 6943 6100 |
| Website | aartipharmalabs.com |
Stock Details
| Ticker Symbol | AARTIPHARM |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE0LRU01027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hetal Gogri Gala | Vice Chairperson and MD |
| Narendra Jagannath Salvi | MD and Director |
| Piyush P. Lakhani | Chief Financial Officer |
| G.M. Naidu | Head of Operations and Manufacturing, CDMO & CMO |
| Sudhakar Shetty | Senior General Manager of Human Resources and Admin |